Drugs Information: Blinatumomab
Basic Information
|
||
| ID | DDInter220 | |
| Drug Type | biotech | |
| Molecular Formula | C2367H3577N649O772S19 | |
| Molecular Weight | - | |
| Description | Blinatumomab is an antineoplastic antibody used to treat Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). | |
| ATC Classification | L01XC19 | |
| IUPAC Name | None | |
| InChI | None | |
| InChI Key | None | |
| Canonical SMILES | None | |
| Useful Links | DrugBank | |
Interactions with Blinatumomab
| Severity level | ID | Name | Mechanism | Detail |
|---|